logo-loader

Scancell Holdings PLC

Receive alerts
Market:
LSE
Market Cap:
£28.39 m
Price
6.10 GBX
Change
-3.94%
52 weeks high
10.33
52 weeks low
3.00

In brief

Cancer remains one of the world’s most significant diseases. A key challenge in the fight against cancer is that many tumours continue to grow by successfully evading the body’s own natural defence mechanism - the immune system. Scancell’s mission is to overcome this breach in our defences by developing products that stimulate the immune system to treat or prevent cancer.

Deep dive We explore the investor case for growth companies

Snapshot

Here we take a closer look at Scancell, which is at the vanguard of immuno-oncology